Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MiroTract
- Development stage
- Unknown
- Lead developer
- Reprise Biomedical
- Administration
- Topical
01
Overview
MiroTract is a porcine liver-derived, three-dimensional wound matrix developed by Reprise Biomedical for the management of acute and chronic wounds. Utilizing a proprietary perfusion decellularization technology, the device maintains a structurally intact collagen scaffold with preserved vascular channels. This architecture is designed to facilitate cellular attachment, proliferation, and integration, thereby supporting the natural wound-healing process. It is indicated for a wide range of conditions, including diabetic foot ulcers, venous leg ulcers, pressure sores, and surgical or traumatic wounds.
- Brand names
- MiroTract
Beyond the preview
Go deeper on MiroTract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MiroTract.